BTG3 and systemic sclerosis: Those with longer SSc duration were more likely to have overlap features (p = 0.013), antinuclear antibody (ANA) centromere positivity (p < 0.001) and were less likely to have Scl-70, Scl/Pm or RNA polymerase-3 positivity (all p < 0.050).